There are four officially recognized categories of diabetes: type 1, type 2, gestational diabetes, and diabetes due to other causes. That last category, though, is a catch-all that contains dozens of distinct conditions, from rare genetic forms to diabetes triggered by other diseases or medications. Depending on how you count, the real number of distinguishable types reaches well into the teens or higher.
The Four Major Categories
The American Diabetes Association uses the same four-category system it has maintained for years: type 1 diabetes, type 2 diabetes, gestational diabetes, and diabetes due to other causes. Most people are familiar with the first three. Type 1 is an autoimmune condition where the body destroys its own insulin-producing cells. Type 2, which accounts for roughly 90 to 95 percent of all cases, involves the body becoming resistant to insulin or not making enough of it. Gestational diabetes develops during pregnancy and typically resolves after delivery, though it raises the long-term risk of developing type 2 later in life.
The fourth category is where things get complicated. “Diabetes due to other causes” covers everything from single-gene mutations to pancreatic disease to drug side effects. Each of these has its own mechanism, progression, and treatment approach, which is why many clinicians and researchers think of diabetes as far more than four diseases.
LADA: The “In-Between” Type
Latent autoimmune diabetes in adults, known as LADA, blurs the line between type 1 and type 2. It’s an autoimmune form of diabetes, like type 1, but it develops slowly in adulthood, typically after age 30. People with LADA can usually manage without insulin for at least six months after diagnosis, which is why it often gets misdiagnosed as type 2.
The key distinguishing feature is the presence of specific autoantibodies in the blood. About 90 percent of LADA patients test positive for GAD65 antibodies, the same immune markers found in type 1 diabetes. Over time, the immune system gradually destroys the insulin-producing cells, and most people with LADA eventually need insulin therapy. Some diabetes organizations consider LADA a slow-progressing subtype of type 1 rather than a separate disease, but the distinction matters because early identification can change treatment decisions.
Monogenic Diabetes: Caused by a Single Gene
Monogenic diabetes results from a mutation in one specific gene, unlike type 1 or type 2, which involve complex interactions between many genes and environmental factors. The two main forms are MODY (maturity-onset diabetes of the young) and neonatal diabetes.
MODY
MODY typically appears before age 25 and runs strongly in families. At least 14 subtypes have been identified, each linked to a different gene. The two most common are HNF1A-MODY, which accounts for 50 to 70 percent of cases, and GCK-MODY, which accounts for 30 to 50 percent. Two other subtypes, HNF4A-MODY and HNF1B-MODY, each make up 5 to 10 percent.
The subtype matters enormously for treatment. GCK-MODY, for example, causes mildly elevated blood sugar that rarely needs medication at all. HNF1A-MODY, on the other hand, often responds well to a class of oral diabetes pills, meaning many patients can avoid insulin. At least ten additional rare MODY subtypes have been identified beyond these four, each with its own clinical profile.
Neonatal Diabetes
Neonatal diabetes appears within the first 12 months of life and can be either permanent or temporary. In the permanent form, mutations in ten different genes have been identified. The most common mutations affect the KCNJ11 gene (34 percent of cases) and the ABCC8 gene (24 percent). This genetic detail is not just academic: babies with mutations in these two genes often respond to oral medications and can sometimes stop insulin injections entirely once genetic testing confirms the diagnosis.
Type 3c: Diabetes From Pancreatic Damage
Type 3c diabetes develops when the pancreas is physically damaged by another condition. The insulin-producing cells are destroyed not by the immune system (as in type 1) but by diseases like chronic pancreatitis, pancreatic cancer, cystic fibrosis, or hemochromatosis, a condition of iron overload. It also occurs after surgical removal of part or all of the pancreas.
Estimates suggest type 3c accounts for 1 to 9 percent of all diabetes cases, a wide range that reflects how frequently it gets misclassified as type 2. People with type 3c often need insulin, and they may also have trouble absorbing nutrients because the same pancreatic damage that disrupts insulin production can impair the digestive enzymes the pancreas normally produces.
Diabetes Caused by Hormonal Disorders
Several hormonal conditions can push blood sugar high enough to cause diabetes. When the body produces too much growth hormone, a condition called acromegaly, the excess hormone ramps up sugar production in the liver while simultaneously making muscles and fat tissue resist insulin. The result is a double hit: more sugar entering the bloodstream and less ability to clear it. Insulin-producing cells can compensate for a while by pumping out extra insulin, but diabetes develops once they can no longer keep up.
A similar process occurs in Cushing syndrome, where excess cortisol drives up blood sugar. In both conditions, treating the underlying hormonal problem can improve or even reverse the diabetes.
Drug-Induced Diabetes
A surprisingly long list of medications can raise blood sugar enough to cause diabetes in susceptible people. The mechanisms vary by drug class.
- Glucocorticoids (steroids like prednisone) cause dose-dependent insulin resistance. At higher doses, the risk climbs significantly.
- Atypical antipsychotics, particularly clozapine and olanzapine, are linked to new-onset diabetes and worsening of existing cases.
- Immunosuppressants used after organ transplants can trigger what’s called post-transplantation diabetes in up to 28 percent of recipients, depending on the drug.
- Thiazide diuretics (a common type of blood pressure pill) can impair insulin release at high doses, partly through potassium depletion.
- HIV protease inhibitors cause new diabetes in 2 to 6 percent of patients taking them, primarily by increasing insulin resistance.
In many of these cases, diabetes improves or resolves if the medication is stopped or the dose is reduced, though that’s not always possible given the condition being treated.
Ketosis-Prone Diabetes
Sometimes called Flatbush diabetes, ketosis-prone diabetes is a form that looks like type 1 at first: patients show up in diabetic ketoacidosis, a dangerous state of very high blood sugar and acid buildup. But unlike type 1, many of these patients recover their insulin-producing ability and can eventually stop taking insulin. It’s more common in people of African, African American, and Hispanic descent.
Clinicians classify it using a system based on two questions: does the patient have autoantibodies, and do their insulin-producing cells still function? This classification predicts with high accuracy whether someone will still need insulin a year later.
The “Type 3 Diabetes” Debate
You may have seen the term “type 3 diabetes” used in connection with Alzheimer’s disease. This is not an officially recognized diagnosis. The term refers to research showing that insulin signaling in the brain doesn’t function properly in Alzheimer’s patients. While the connection between insulin resistance and cognitive decline is an active area of study, no medical organization currently lists type 3 diabetes as a formal category.
Five Clusters That Could Reshape Classification
A landmark study published in The Lancet Diabetes & Endocrinology proposed splitting adult-onset diabetes into five distinct clusters based on six measurable variables, including autoantibodies, age at diagnosis, BMI, blood sugar control, and estimates of insulin production and resistance. The five groups are: severe autoimmune diabetes (similar to type 1), severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes, and mild age-related diabetes.
Each cluster carried different risks for complications. People in the severe insulin-resistant group, for instance, had significantly higher rates of kidney disease, while the severe insulin-deficient group faced more eye complications. This framework hasn’t replaced the current four-category system, but it reflects a growing recognition that “type 2 diabetes” likely contains several meaningfully different conditions that may benefit from different treatment strategies.